Ticagrelor for PCI Post Thrombolysis

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
Acute Myocardial Infarction
Interventions
DRUG

Ticagrelor

180 mg bolus followed by 90 mg BID

DRUG

Clopidogrel

300 mg bolus followed by 75 mg OD

Trial Locations (5)

L8L 2X2

Hamilton General Hospital, Hamilton

N6A 5W9

London Health Sciences Centre, London

L3Y 2R2

Southlake Regional Health Centre, Newmarket

M5B 1W8

St. Michael's Hospital, Toronto

S4P 0W5

Prairie Vascular Research Inc. (PVRI), Regina General Hospital, Regina

All Listed Sponsors
collaborator

Prairie Vascular Research Inc.

INDUSTRY

lead

Unity Health Toronto

OTHER

NCT01930591 - Ticagrelor for PCI Post Thrombolysis | Biotech Hunter | Biotech Hunter